BRPI0514265A - método para detectar cáncer da tireóide em um paciente, e, ensaio pré-operatório para determinar se a neoplasia da tireóide em um paciente é benigna ou maligna - Google Patents
método para detectar cáncer da tireóide em um paciente, e, ensaio pré-operatório para determinar se a neoplasia da tireóide em um paciente é benigna ou malignaInfo
- Publication number
- BRPI0514265A BRPI0514265A BRPI0514265-2A BRPI0514265A BRPI0514265A BR PI0514265 A BRPI0514265 A BR PI0514265A BR PI0514265 A BRPI0514265 A BR PI0514265A BR PI0514265 A BRPI0514265 A BR PI0514265A
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- thyroid cancer
- preoperative
- assay
- detecting
- Prior art date
Links
- 208000024770 Thyroid neoplasm Diseases 0.000 title abstract 5
- 201000002510 thyroid cancer Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000003556 assay Methods 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title 1
- 102000003911 Thyrotropin Receptors Human genes 0.000 abstract 2
- 108090000253 Thyrotropin Receptors Proteins 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 102000009843 Thyroglobulin Human genes 0.000 abstract 1
- 108010034949 Thyroglobulin Proteins 0.000 abstract 1
- 229960002175 thyroglobulin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60058904P | 2004-08-11 | 2004-08-11 | |
| PCT/US2005/028688 WO2006020837A2 (en) | 2004-08-11 | 2005-08-11 | Method of detecting thyroid cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514265A true BRPI0514265A (pt) | 2008-06-10 |
Family
ID=35908168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514265-2A BRPI0514265A (pt) | 2004-08-11 | 2005-08-11 | método para detectar cáncer da tireóide em um paciente, e, ensaio pré-operatório para determinar se a neoplasia da tireóide em um paciente é benigna ou maligna |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070065833A1 (enExample) |
| EP (1) | EP1778872A2 (enExample) |
| JP (1) | JP2008509672A (enExample) |
| KR (1) | KR20070044048A (enExample) |
| AU (2) | AU2005272696A1 (enExample) |
| BR (1) | BRPI0514265A (enExample) |
| CA (1) | CA2576912A1 (enExample) |
| WO (1) | WO2006020837A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| US8394580B2 (en) * | 2007-08-17 | 2013-03-12 | The Johns Hopkins University | Protein markers for the detection of thyroid cancer metastasis |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| EP3831954A3 (en) | 2008-11-17 | 2021-10-13 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US20110312520A1 (en) | 2010-05-11 | 2011-12-22 | Veracyte, Inc. | Methods and compositions for diagnosing conditions |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| ES3015226T3 (en) | 2012-08-16 | 2025-04-30 | Veracyte Sd Inc | Prostate cancer prognosis using biomarkers |
| BR112015022490A2 (pt) | 2013-03-15 | 2017-07-18 | Veracyte Inc | métodos e composições para classificação de amostras |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
| CN113082201B (zh) | 2016-04-01 | 2024-07-05 | 上海斯丹赛生物技术有限公司 | 刺激t细胞介导的对表达抗原的细胞群的免疫应答的方法 |
| US10654934B2 (en) | 2016-04-01 | 2020-05-19 | Innovative Cellular Therapeutics CO., LTD. | Use of chimeric antigen receptor modified cells to treat cancer |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| AU2018230784A1 (en) | 2017-03-09 | 2019-10-10 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| CN108089011A (zh) * | 2018-01-09 | 2018-05-29 | 广州市康润生物科技有限公司 | 一种快速免疫检测系统在手术中的新用途 |
| KR102745894B1 (ko) * | 2019-04-05 | 2024-12-23 | 주식회사 제놉시 | Cfdna를 이용한 방광암 진단방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391579B1 (en) * | 1996-02-01 | 2002-05-21 | Albert Einstein College Of Medicine Of Yeshiva University | Thyroid sodium/iodide symporter and nucleic acid encoding same |
| US6066449A (en) * | 1997-04-15 | 2000-05-23 | The Trustees Of Columbia University In The City Of New York | Method of detecting metastatic thyroid cancer |
| WO1998056953A1 (en) * | 1997-06-10 | 1998-12-17 | Johns Hopkins University School Of Medicine | Methods for thyroid cell detection |
| US20020009778A1 (en) * | 1998-05-29 | 2002-01-24 | Incyte Pharmaceuticals, Inc. | Thyroid and pituitary membrane protein |
| US6436642B1 (en) * | 1999-04-20 | 2002-08-20 | Curagen Corporation | Method of classifying a thyroid carcinoma using differential gene expression |
-
2005
- 2005-08-11 EP EP05786259A patent/EP1778872A2/en not_active Withdrawn
- 2005-08-11 US US11/201,508 patent/US20070065833A1/en not_active Abandoned
- 2005-08-11 JP JP2007525816A patent/JP2008509672A/ja active Pending
- 2005-08-11 AU AU2005272696A patent/AU2005272696A1/en not_active Abandoned
- 2005-08-11 WO PCT/US2005/028688 patent/WO2006020837A2/en not_active Ceased
- 2005-08-11 KR KR1020077005647A patent/KR20070044048A/ko not_active Ceased
- 2005-08-11 BR BRPI0514265-2A patent/BRPI0514265A/pt not_active IP Right Cessation
- 2005-08-11 CA CA002576912A patent/CA2576912A1/en not_active Abandoned
-
2009
- 2009-08-21 AU AU2009210417A patent/AU2009210417A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1778872A2 (en) | 2007-05-02 |
| US20070065833A1 (en) | 2007-03-22 |
| WO2006020837A2 (en) | 2006-02-23 |
| CA2576912A1 (en) | 2006-02-23 |
| AU2009210417A1 (en) | 2009-09-10 |
| WO2006020837A3 (en) | 2006-09-28 |
| JP2008509672A (ja) | 2008-04-03 |
| AU2005272696A1 (en) | 2006-02-23 |
| KR20070044048A (ko) | 2007-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hiramatsu et al. | N 1, N 12-diacetylspermine as a sensitive and specific novel marker for early-and late-stage colorectal and breast cancers | |
| WO2006020837A3 (en) | Method of detecting thyroid cancer | |
| Bartsch et al. | Nocturnal urinary 6‐sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age‐matched controls and shows negative correlation with tumor‐size | |
| US20140206015A1 (en) | Method for detecting nucleosomes | |
| BRPI0513692B8 (pt) | processos para detecção de câncer de bexiga em um indivíduo | |
| Hopkins et al. | Oncofetal gene SALL4 in aggressive hepatocellular carcinoma | |
| ATE365922T1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| BRPI0412725A (pt) | marcadores para detecção de cáncer gástrico | |
| EP1842065A4 (en) | METHODS OF DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS | |
| EP2901151A1 (en) | Diagnostic devices and methods | |
| WO2004076643A3 (en) | CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS | |
| EP1838867A4 (en) | APOLIPOPROTEIN A II ISOFORM AS A BIOMARKER FOR PROSTATE CANCER | |
| EP1183390B8 (en) | METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY | |
| ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| Sulaieva et al. | Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: relation to outcomes? | |
| Fujimoto et al. | Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers | |
| Banfalvi et al. | Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma | |
| Hernandez et al. | BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis | |
| Moradi et al. | Quantitative detection of SRY-Box 21 (SOX21) gene promoter methylation as a stool-based noninvasive biomarker for early diagnosis of colorectal cancer by MethyLight method | |
| US10174385B2 (en) | Assays and methods relating to the treatment of melanoma | |
| BR9914161A (pt) | Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra | |
| Kuerer et al. | High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer | |
| Baron et al. | A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women | |
| Li et al. | Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue | |
| Poon et al. | Correlation and prognostic significance of beta-galactoside alpha-2, 6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |